Soluble ST2 as a biomarker for predicting severe adverse events among pediatric patients with Mycoplasma pneumoniae pneumonia

• Fangying Cheng ,

  Contributed equally to this work with: Fangying Cheng, Tingting Li

  Roles Writing – original draft

  Affiliation Department of Clinical Laboratory, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China

  ⨯
• Tingting Li ,

  Contributed equally to this work with: Fangying Cheng, Tingting Li

  Roles Writing – original draft

  Affiliation Department of Clinical Laboratory, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China

  ⨯
• Lei Zhang,

  Roles Investigation

  Affiliation Department of Clinical Laboratory, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China

  ⨯
• Menghua Xu,

  Roles Formal analysis

  Affiliation Department of Clinical Laboratory, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China

  ⨯
• Luxi Chen,

  Roles Methodology

  Affiliation Department of Clinical Laboratory, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China

  ⨯
• Zhicheng Ye ,

  Roles Writing – review & editing

  * E-mail: yzcrxj@163.com (ZY); jinxu_125@163.com (JX)

  Affiliation Department of Clinical Laboratory, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China

  https://orcid.org/0009-0009-6967-6969

  ⨯
• Jin Xu

  Roles Writing – review & editing

  * E-mail: yzcrxj@163.com (ZY); jinxu_125@163.com (JX)

  Affiliation Department of Clinical Laboratory, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China

  ⨯